Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,065 across all filing types
Latest filing 2020-09-17 Regulatory Filings
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
CLARIFICATION ANNOUNCEMENT REGARDING BOOK CLOSURE DATES
Regulatory Filings Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding the clarification of book closure dates for shareholder registration related to two extraordinary general meetings (EGMs). It references notices and circulars but does not contain any financial statements, detailed financial data, or management discussion. The document is relatively short (3329 characters) and serves to clarify procedural details about shareholder registration and voting rights for upcoming meetings. This fits the description of a Declaration of Voting Results & Voting Rights Announcement (DVA) or a Regulatory Filing (RNS). However, since it is about clarifying book closure dates for voting entitlement rather than announcing voting results, it is more appropriate to classify it as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories. Therefore, the classification is RNS with high confidence.
2020-09-17 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Uni-Bio Science Group Limited. It includes detailed information on shares repurchased, dates, prices, and confirmations that the repurchases comply with listing rules. The content focuses on reporting share repurchase activity and changes in issued shares, which aligns with announcements regarding share repurchases or capital changes. There is no indication that this is a full financial report, earnings release, or management discussion. The document is not a proxy statement, AGM material, or legal proceeding. Given the detailed disclosure of share repurchase transactions and changes in issued share capital, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support this classification with high confidence.
2020-09-16 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Uni-Bio Science Group Limited. It details the number of shares repurchased, dates, prices, and confirms compliance with listing rules. The content focuses on share repurchase activity and changes in capital, not on financial results, management changes, or other report types. The document length is 8721 characters, which is substantive and contains detailed transactional data. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares (share repurchase/issuance).
2020-09-15 English
NOTIFICATION LETTER AND REQUEST FORM
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 15 September 2020 from Uni-Bio Science Group Limited informing shareholders that the 2020 interim report for the six months ended 30 June 2020 has been published on the company's website. It includes instructions on how shareholders can request a printed copy of the interim report and other corporate communications. The document does not contain the interim report itself or any substantive financial data, but rather serves as a notice of publication and availability of the report. The document length is 4666 characters, which is relatively short and consistent with a notification rather than a full report. Therefore, according to the 'Menu vs Meal' rule, this document should be classified as a Report Publication Announcement (RPA) rather than an Interim Report (IR).
2020-09-15 English
Interim Report 2020
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data for the six months ended 30 June 2020, including condensed consolidated statements of profit or loss, financial position, cash flows, and changes in equity. It also includes management discussion and analysis (MD&A) sections discussing market review, business review, key accomplishments, and R&D pipeline progress. The presence of unaudited condensed consolidated interim results and substantive financial data for a half-year period indicates this is an Interim / Quarterly Report. The document length is about 15,000 characters, which is consistent with a full interim report rather than a brief announcement or certification. There is no indication that this is an annual report, audit report, or earnings release. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2020
2020-09-15 English
NOTIFICATION LETTER AND REQUEST FORM
Report Publication Announcement Classification · 100% confidence The document is a notification letter to non-registered shareholders informing them about the publication of certain corporate communications on the company's website. It specifically mentions circulars regarding a proposed change of auditor, discloseable and connected transactions, variation of terms to transaction arrangements, and notices of extraordinary general meetings. The document also includes a request form for shareholders to receive printed copies of these communications. The text explicitly states that the corporate communications include documents such as annual reports, interim reports, notices of meetings, listing documents, and circulars. However, this document itself is not the report or circular but a notification about their availability and how to request printed copies. The document length is under 5,000 characters and serves as an announcement rather than containing substantive financial or corporate data. Therefore, according to the MENU VS MEAL RULE and the nature of the content, this document should be classified as a Report Publication Announcement (RPA).
2020-09-14 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.